| WAVE LIFE SCIENCES LTD. |
| Singapur |
| Gesundheit |
| SG9999014716 / A1436W |
| 1U5 (Frankfurt) / WVE (NASDAQ) |
| FRA:1U5, ETR:1U5, 1U5:GR, NASDAQ:WVE |
| - |
| https://wavelifesciences... |
|
Wave Life Sciences Ltd. is a biotechnology company engaged in the research and development of stereopure nucleic acid therapies. The primary focus of Wave Life Sciences is to leverage its unique platform to design and optimize therapies that modulate..
>Volltext.. |
| 1041.28 Mio. EUR |
| 549.56 Mio. EUR |
| 37.13 Mio. EUR |
| -179.48 Mio. EUR |
| -177.6 Mio. EUR |
| -1.05 EUR |
| 15.44 Mio. EUR |
| 523.2 Mio. EUR |
| -164.25 Mio. EUR |
| 6.33 |
| -65.23% |
| -85.7% |
| - |
| - |
| - |
| WAVE LIFE SCIENCES |
| 30.03.26 |
|